This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_VULVA_EXALLC for full statistics.
Malignant neoplasm of vulva
DOID EFO MESH SNOMED Endpoint Browser
C3_VULVA
vulvar carcinoma: A carcinoma that arises from epithelial cells of the mammalian vulva
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule
Sex
only females
239906
Check conditions None
239906
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C51
Cause of death: ICD-9
184[1-4]
Cause of death: ICD-8
1841
Cancer registry: Topography ICD-O-3
C51
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
210
Check minimum number of events None
210
Include endpoints None
210
Remove individuals based on genotype QC
202
C3_VULVA
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of vulva
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of vulva (controls excluding all cancers)
- malignant neoplasm of female genital organs (controls excluding all cancers)
- malignant neoplasm of female genital organs
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 202 | 202 | - |
| Unadjusted prevalence (%) | 0.05 | 0.09 | - |
| Mean age at first event (years) | 65.32 | 65.32 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_VULVA – Malignant neoplasm of vulva
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of vulva
↥Endpoint not on priority list, no data to show.